- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Submit a Manuscript
- Table of Contents
Case Reports in Dentistry
Volume 2012 (2012), Article ID 902858, 6 pages
Platelet-Rich Fibrin with β-Tricalcium Phosphate—A Noval Approach for Bone Augmentation in Chronic Periapical Lesion: A Case Report
1Department of Conservative Dentistry and Endodontics, Peoples College of Dental Sciences & Research Centre, Bhopal 462037, India
2Century Dental College, Kerala, Poinachi 671541, India
Received 19 August 2012; Accepted 25 September 2012
Academic Editors: A. C. B. Delbem, M. B. D. Gaviao, and P. Lopez Jornet
Copyright © 2012 K. B. Jayalakshmi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. This paper describes a case of bone augmentation with combination of Platelet-Rich Fibrin (PRF) and β-TCP for treatment of chronic periapical cyst. The case was followed for 12 months. Methods. Patient presented with chronic periapical lesion in maxillary anterior teeth with history of trauma 8 years back. Radiographically, a periapical cyst was seen in relation to maxillary left central and lateral incisors. Conventional endodontic treatment was started. Since it was not successful, apical surgery was performed. Bone augmentation was done using PRF in combination with β-TCP bone graft to achieve faster healing of the periapical region. Regular followups at 3, 6, 9, and 12 months were done. Results. Healing was uneventful. Follow-up examinations revealed progressive, significant, and predictable clinical and radiographic bone regeneration/healing without any clinical symptoms. Conclusions. Combined use of PRF and β-TCP for bone augmentation in treatment of periapical defects is a potential treatment alternative for faster healing than using these biomaterials alone.
Bacterial infection of the dental pulp may lead to periapical lesions . They are generally diagnosed either during routine dental radiographic examination or following acute pain and/or swelling in relation to the affected tooth . Most periapical lesions (>90%) can be classified as dental granulomas, abscesses, or radicular cysts [3, 4]. The incidence of cysts within periapical lesions varies between 6 and 55% . The occurrence of periapical granulomas ranges between 9.3 and 87.1%, and of abscesses between 28.7 and 70.07% .
The ultimate goal of endodontic therapy is to return the involved tooth to a state of health and function . All inflammatory periapical lesions should be initially treated with conventional endodontic therapy  which has shown success in 85% of cases [9–11]. However failure after conventional root canal treatment calls for surgical intervention . Periapical Surgery has many limitations, like it is an invasive procedure, has psychological impact on the patient, and requires skilled and experienced operator [13, 14]. Nevertheless, periapical surgery remains the last resort when root canal treatment either fails or is not possible.
Traditional surgical approaches to treat periapical defects include debridement of apical lesions along with reshaping of the surrounding bone, resection, and retro filling of root apex, where healing is almost always by repair . Repair is defined as the healing of a wound by tissue that does not fully restore the architecture or the function of the part . Since this is not ideal, newer approaches such as regenerative procedures that aim to restore lost tissue have been introduced.
Beta-tricalcium phosphate (β-TCP) is an alloplast widely used in periapical surgery to enhance new bone formation. It is an osteoconductive bone graft which gets chemically resorbed with a concomitant release of bioactive ions .
More number of platelets deliver an increased number of polypeptide growth factors that regulate cell proliferation, chemotaxis, and differentiation to the surgical area . Platelet rich plasma (PRP), first generation of autologous platelet concentrate, has been used for the purpose of tissue regeneration [17, 18]. Although its use has shown clinical success its complex preparation protocol and moderate benefits limit its usage in regenerative surgeries [19, 20].
Platelet rich fibrin (PRF), introduced by Choukroun et al. in the year 2001, is a second-generation platelet concentrate enriched with platelets and growth factors which promote periapical tissue regeneration and healing. Unlike PRP, it is obtained from a anticoagulant and thrombin free blood harvest making it free from the risk of disease transmission .
In the present case an innovative idea of combining PRF with a β-tricalcium phosphate was used. Indeed, separate studies have shown clinical success in bone formation with the use of both these materials used separately. This case report presents an attempt to evaluate the healing kinetics of the combination of PRF and β-tricalcium phosphate as opposed to using these materials alone.
2. Case Report
A 25-year-old female reported to the Department of Conservative Dentistry and Endodontics with chief complaint of swelling and pus discharge from upper front tooth region since 1 month. Past dental history revealed trauma which she sustained 8 yrs back in the same region. On intraoral examination, there was a draining sinus, in relation to the apex of 21. On Electric pulp testing, tooth number 22 was also found nonvital. Periapical radiograph revealed a large diffused periapical radiolucency in relation to 21 and 22 measuring 1.4 cm in diameter (Figure 1).
Culture and sensitivity test revealed presence of Pseudomonas aeruginosa. Accordingly an antibiotic course of cefixime 400 mg twice daily and metronidazole 200 mg thrice daily were advised to the patient for 7 days.
Conventional RCT was started with 21 and 22. Since it was not successful it was decided to surgically debride the lesion, with root resection followed by retrograde restoration. In order to achieve optimal healing and regeneration of bone, it was planned to use PRF in combination with bone graft. An ethical clearance was obtained from the institutional ethical committee. Patient consent was taken after careful explanation of the surgical procedure used and the risks and benefits.
Before the surgery, patient’s complete hemogram was done and all the parameters were found to be within normal limits.
Intraoral and extraoral antisepsis was performed using 0.2% chlorhexidine digluconate rinse and povidone iodine solution, respectively. Following administration of local anaesthesia, submarginal incision was given 3 mm apical the marginal gingiva and mucoperiosteal flap was reflected (Figure 2). Meticulous defect debridement was done; 21 and 22 were then obturated using lateral and vertical condensation technique.
PRF was prepared in accordance with the protocol developed by Freymiller and Aghaloo . Intravenous blood (by venipuncturing of the antecubital vein) was collected (Figure 3) in a 10 mL sterile tube without anticoagulant and immediately centrifuged at 3,000 rpm for 10 minutes. Blood centrifugation allowed the formation of a structured fibrin clot in the middle of the tube, just between the red corpuscles at the bottom and acellular plasma (platelet-poor plasma) at the top. PRF was easily separated from red corpuscles base (preserving a small RBC layer) using sterile tweezers (Figure 4) just after removal of PPP (platelet-poor plasma) and then transferred into a sterile dappen dish.
PRF was mixed with β-tricalcium phosphate and augmented into the intrabony defect upto the surrounding bone level (Figure 5). The mucoperiosteal flap was repositioned and simple interrupted sutures were given using 3–0 nonabsorbable black silk suture.
Post-operative care was explained to the patient, with instructions to report back after a week for suture removal. Recall examinations after 3-, 6-, 9-, and 12-month interval were done to evaluate the healing kinetics of the periapical defect.
Regeneration is defined as reproduction or reconstitution of a lost or injured part which fully restores the architecture or function of the part .
Regeneration of tissue after periapical surgery requires (a) recruitment of progenitor/stem cells to differentiate into committed cells, (b) growth/differentiation factors as necessary signals for attachment, migration, proliferation and differentiation of cells, and (c) local-microenvironmental cues like adhesion molecules, extra cellular matrix, associated non-collagenous protein molecules, and so forth. Lack of any of these elements would result in repair rather than regeneration .
Perhaps the most commonly used technique for regeneration is the use of bone replacement grafts. These grafts can promote tissue or bone regeneration through variety of mechanisms.
Bone grafting materials include autografts, allograft, xenografts, and alloplasts. Alloplasts such as osteoconductive calcium phosphate have been widely used in periapical surgery to enhance new bone formation . Several case reports have demonstrated healing with mature bone and haemopoietic marrow in periapical areas by using this bone graft [23–25].
To promote periapical tissue regeneration and healing, local application of growth factors and host modulating agents is being used to maximize the body’s healing potential. TGF-beta and PDGF are the typical two growth factors which promote healing of soft tissue and bone through stimulation of collagen production to improve wound strength and initiation of callus formation . PDGF is aregulator for migration, proliferation, and survival of mesenchymal cell lineages. TGF-beta constitutes the most powerful fibrosing agent among all cytokines. It induces massive synthesis of matrix molecules such as collagen-I and fibronectin either by osteoblasts or fibroblasts. Although its regulation mechanism is particularly complex, it is considered as an inflammation regulator through its capacity to induce fibrous cicatrization. Basic studies have demonstrated that specialized secretory granules of platelets, such as alpha-granules, contain these growth factors [26, 27]. Growth factors are known to attract stem cells present in apical tissues .
Platelet-rich plasma (PRP) has been used clinically to stimulate bone regeneration although its real efficacy is debated . It has been suggested to mediate only the early aspects of bone regeneration . Its long-term predictability remains questionable, and the anticipated benefits are moderate .
PRF helps to obtain fibrin membranes enriched with platelets and growth factors. PRF by Choukroun’s technique is produced in a natural manner, without using an anticoagulant, bovine thrombin, or calcium chloride for platelet activation and fibrin polymerization .
In vitro studies have proved that PRF releases autologous growth factors gradually for at least 1 week and up to 28 days . The natural and slow polymerization occurring during centrifugation process of PRF leads to formation of a homogenous 3-dimensional organization of the fibrin network. The absence of anticoagulant in the test tube leads to massive platelet activation, bolstered by the presence of a mineral phase on the tube walls (residual glass particles). A progressive polymerization mode signifies increased incorporation of the circulating cytokines in the fibrin meshes (intrinsic cytokines). This configuration increases the lifespan of these cytokines, as they are released and used only at the time of initial cicatricial remodeling . PRF has a stronger and more durable effect than PRP .
Marx et al. in their study added PRP to bone grafts used in mandibular bone defects and evidenced that radiographically the maturation rate was better than that of grafts without platelet-rich plasma . Wiltfang et al. reported 8% to 10% more bone formation when PRP was added to tricalcium phosphate .
In another study Goyal et al. compared the healing responses of PRP with guided tissue regeneration Membrane and found significant healing in the treatment of apicomarginal defects . In addition Taschieri et al. also used combination of autologous growth factors with xenogenic bone grafts in treatment of through and through bone lesions and observed a fast and predictable tissue healing .
The healing potential of PRF combined with β-TCP has not been studied in endodontics. Kim et al. combined PRF with β-TCP and observed rapid bone formation, remodeling, and calcification in the second week than the β-TCP alone in rabbits .
In the present case, it was observed that at 3- (Figure 6), 6- (Figure 7), 9- (Figure 8), and 12- (Figure 9) month followup after the surgical treatment of large chronic periapical lesion, PRF combined with beta-tricalcium resulted in significant, progressive, and predictable clinical and radiographic bone regeneration.
Besides promoting wound healing, bone growth, and maturation, PRF mixed with β-tricalcium phosphate bone graft has the advantages of graft stabilization, wound sealing, hemostasis, and improved handling properties .
However, like other clinical studies this study also has few limitations like short follow-up period of 12 months and a need for histological evaluation to confirm regeneration.
From the present case report, where PRF and β-Tricalcium Phosphate allograft were used for periapical healing, following conclusions can be drawn.(i)Addition of PRF to β-Tricalcium Phosphate allograft accelerates regenerative capacity of bone.(ii)When used in combination, they give a predictable clinical and radiographic evidence of bone formation.
Conflict of Interests
The authors deny any conflict of interests.
- A. J. R. Möller, L. Fabricius, G. Dahlen, A. E. Ohman, and G. Heyden, “Influence on periapical tissues of indigenous oral bacteria and necrotic pulp tissue in monkeys,” Scandinavian Journal of Dental Research, vol. 89, no. 6, pp. 475–484, 1981.
- F. H. Barbakow, P. E. Cleaton-Jones, and D. Friedman, “Endodontic treatment of teeth with periapical radiolucent areas in a general dental practice,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 51, no. 5, pp. 552–559, 1981.
- S. N. Bhaskar, “Oral surgery-oral pathology conference no. 17, Walter Reed Army Medical Center. Periapical lesions-types, incidence, and clinical features,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 21, no. 5, pp. 657–671, 1966.
- E. R. Lalonde and R. G. Luebke, “The frequency and distribution of periapical cysts and granulomas. An evaluation of 800 specimens,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 25, no. 6, pp. 861–868, 1968.
- P. N. R. Nair, G. Pajarola, and H. E. Schroeder, “Types and incidence of human periapical lesions obtained with extracted teeth,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 81, no. 1, pp. 93–102, 1996.
- M. Schulz, T. von Arx, H. J. Altermatt, and D. Bosshardt, “Histology of periapical lesions obtained during apical surgery,” Journal of Endodontics, vol. 35, no. 5, pp. 634–642, 2009.
- K. Salamat and R. F. Rezai, “Nonsurgical treatment of extraoral lesions caused by necrotic nonvital tooth,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 61, no. 6, pp. 618–623, 1986.
- L. M. Lin, G. T. J. Huang, and P. A. Rosenberg, “Proliferation of epithelial cell rests, formation of apical cysts, and regression of apical cysts after periapical wound healing,” Journal of Endodontics, vol. 33, no. 8, pp. 908–916, 2007.
- U. Sjögren, B. Hägglund, G. Sundqvist, and K. Wing, “Factors affecting the long-term results of endodontic treatment,” Journal of Endodontics, vol. 16, no. 10, pp. 498–504, 1990.
- M. K. Çalişkan and B. H. Şen, “Endodontic treatment of teeth with apical periodontitis using calcium hydroide: a long-term study,” Endodontics and Dental Traumatology, vol. 12, no. 5, pp. 215–221, 1996.
- N. Shah, “Nonsurgical management of periapical lesions: a prospective study,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 66, no. 3, pp. 365–371, 1988.
- E. Nicholls, Endodontics, John Wright Sons, Bristol, UK, 3rd edition, 1984.
- E. J. Neaverth and H. A. Burg, “Decompression of large periapical cystic lesions,” Journal of Endodontics, vol. 8, no. 4, pp. 175–182, 1982.
- T. L. Walker and M. S. Davis, “Treatment of large periapical lesions using cannulization through the involved teeth,” Journal of Endodontics, vol. 10, no. 5, pp. 215–220, 1984.
- J. D. Bashutski and H. L. Wang, “Periodontal and endodontic regeneration,” Journal of Endodontics, vol. 35, no. 3, pp. 321–328, 2009.
- Glossary of Periodontal Terms, American Academy of Periodontology, Chicago, Ill, USA, 2001.
- R. E. Marx, E. R. Carlson, R. M. Eichstaedt, S. R. Schimmele, J. E. Strauss, and K. R. Georgeff, “Platelet-rich plasma: growth factor enhancement for bone grafts,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 85, no. 6, pp. 638–646, 1998.
- B. Goyal, S. Tewari, J. Duhan, and P. K. Sehgal, “Comparative evaluation of platelet-rich plasma and guided tissue regeneration membrane in the healing of apicomarginal defects: a clinical study,” Journal of Endodontics, vol. 37, no. 6, pp. 773–780, 2011.
- E. G. Freymiller and T. L. Aghaloo, “Platelet-rich plasma: ready or not?” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 4, pp. 484–488, 2004.
- D. M. Dohan, J. Choukroun, A. Diss et al., “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 101, no. 3, pp. E37–E44, 2006.
- S. Taschieri, M. Del Fabbro, T. Testori, and R. Weinstein, “Efficacy of xenogeneic bone grafting with guided tissue regeneration in the management of bone defects after surgical endodontics,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 6, pp. 1121–1127, 2007.
- L. Lin, Y. H. Melody, D. Ricucci, and P. A. Rosenberg, “Guided tissue regeneration in periapical surgery,” Journal of Endodontics, vol. 36, no. 4, pp. 618–625, 2010.
- F. Brugnami and J. T. Mellonig, “Treatment of a large periapical lesion with loss of labial cortical plate using GTR: a case report,” International Journal of Periodontics and Restorative Dentistry, vol. 19, no. 3, pp. 243–249, 1999.
- V. S. Pinto, M. L. Zuolo, and J. T. Mellonig, “Guided bone regeneration in the treatment of a large periapical lesion: a case report,” Practical Periodontics and Aesthetic Dentistry, vol. 7, no. 2, pp. 76–82, 1995.
- C. C. Tseng, Y. H. Chen, C. C. Huang, and G. M. Bowers, “Correction of a large periradicular lesion and mucosal defect using combined endodontic and periodontal therapy: a case report,” The International Journal of Periodontics & Restorative Dentistry, vol. 15, no. 4, pp. 377–383, 1995.
- X. E. Dereka, C. E. Markopoulou, and I. A. Vrotsos, “Role of growth factors on periodontal repair,” Growth Factors, vol. 24, no. 4, pp. 260–267, 2006.
- W. V. Giannobile, R. A. Hernandez, R. D. Finkelman et al., “Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis,” Journal of Periodontal Research, vol. 31, no. 5, pp. 301–312, 1996.
- M. Torabinejad and M. Turman, “Revitalization of tooth with necrotic pulp and open apex by using platelet-rich plasma: a case report,” Journal of Endodontics, vol. 37, no. 2, pp. 265–268, 2011.
- K. A. Schlegel, K. Donath, S. Rupprecht et al., “De novo bone formation using bovine collagen and platelet-rich plasma,” Biomaterials, vol. 25, no. 23, pp. 5387–5393, 2004.
- L. He, Y. Lin, X. Hu, Y. Zhang, and H. Wu, “A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 108, no. 5, pp. 707–713, 2009.
- D. M. Dohan, J. Choukroun, A. Diss et al., “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 101, no. 3, pp. E45–E50, 2006.
- J. Wiltfang, K. A. Schlegel, S. Schultze-Mosgau, E. Nkenke, R. Zimmermann, and P. Kessler, “Sinus floor augmentation with β-tricalciumphosphate (β-TCP): does platelet-rich plasma promote its osseous integration and degradation?” Clinical Oral Implants Research, vol. 14, no. 2, pp. 213–218, 2003.
- B. J. Kim, T. K. Kwon, H. S. Baek et al., “A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet-rich fibrin-mixed tricalcium phosphate in rabbits,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 113, pp. 583–592, 2012.
- S. E. Raja and M. E. Naidu, “Platelet-rich fibrin: evolution of a second-generation platelet concentrate,” Indian Journal of Dental Research, vol. 19, no. 1, pp. 42–46, 2008.